Wanbury (WANBURY.NS) Stock Price

Wanbury Price

CLOSED
194.74
​
Market closed

Over the last 20 years Wanbury grew revenue by 9.4% annually, reaching 6.50 B INR. Earnings per share have grown at 4.1% per year over the last 20 years. For Wanbury, the net margin of 10.2% is down versus 15.9% a few years ago. At today's price the dividend yield works out to roughly 0.51%. The payout ratio is around 42% of earnings. The dividend has grown at 41.4% per year over the past 2 years.

Wanbury stock price

Access this data via the Eulerpool API

Wanbury business model & stock analysis

Wanbury Ltd. engages in the business of pharmaceutical and related activities, including research. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 1,582 full-time employees. The firm is engaged in the business of pharmaceutical and related activities, including research. The firm operates through two divisions: the Active Pharmaceutical Ingredients (API) Business and the Domestic Formulations Business. The Company, through the Active Pharmaceutical Ingredients (API) Business, provides Metformin and Sertraline. Metformin is used for the treatment for type 2 diabetes and Sertraline is an anti-depressant. The company has approximately 13 API products. The company manufactures Metformin with over 8500 tons per year. Its products include Metformin HCL, Metformin DC/SR, Sertraline, Diphenhydramine, Mefenamic Acid, Glucosamine, Methoxsalen and Paroxetine. The firm's subsidiaries include Wanbury Holdings B. V. (Netherland), Wanbury Global FZE (UAE), Ningxia Wanbury Fine Chemicals Co. Ltd. (China) and Cantabria Pharma S. L. (Spain).

Frequently asked questions about Wanbury

Converted at the current exchange rate, the Wanbury share trades at 1.80 EUR (194.74 INR).

The revenue of Wanbury is 6.50 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Wanbury is 661.35 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Wanbury is currently 10.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Wanbury stock.

The price-to-sales ratio (P/S) of Wanbury is currently 1.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Wanbury stock.

The Eulerpool Quality Score for Wanbury is 5/10.

The ISIN of Wanbury is INE107F01022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Wanbury is WANBURY.NS. The ticker symbol is used to trade Wanbury shares on the stock exchange.

Fair ValueTerminal
198.63 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
4.11 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website wanbury.com
Country
Currency
INR
Initial public offering
Feb 24, 1992
ISIN
INE107F01022
Cusip
Y6802L111
Market capitalization
6.80 B INRMid Cap
52-Week Range
PEG
0.44
P/E ratio
P/Ee 2027
8.05
P/Ee 2028
5.58
P/Ee 2029
4.21
P/Ee 2030
3.48
P/S
P/Se
0.78
EV/EBIT
9.77
P/B Ratio
4.71
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
17.93 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
0.51 %
Payout Ratio
41.52 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 9, 2026, 3:54 PM

Wanbury Peer Group

Wanbury FIGI

WANB:IN · BBG000CXNB49WANB:IB · BBG000CXNBK1WANB:IS · BBG000CXNC56

All fundamentals and in-depth analysis of Wanbury

Our stock analysis for Wanbury stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wanbury. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.